AGING CELL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1248213, encodeId=46f912482132d, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 已经两个多月了，想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=ms4000000851485808, createdTime=Fri Sep 09 21:44:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248205, encodeId=0cdc12482058a, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=12307963m39暂无昵称, createdTime=Fri Sep 09 21:19:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147495, encodeId=4453214e49507, content=投稿命中率:25.0 经验分享：2022/10/31 投稿 2022/11/4 With supervising editor 2022/11/5 Under review 2022/11/14 In Review 2022/12/1 Decision：Major revision 2023/5/8 Revision submitted 2023/6/5 Decision： Minor revision 2023/6/14 Revision submitted 2023/6/14 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Jul 11 16:07:53 CST 2023, time=2023-07-11, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2153075, encodeId=03fd21530e538, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.3.7提交 2023.4.20审稿意见回来 major revision 2023.6.15 提交返修稿 2023.8.8 接收 想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed Aug 16 19:13:02 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向：骨健康;蛋白质组 经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2136489, encodeId=3113213648953, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed May 17 12:20:19 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0 偏重的研究方向：细胞衰老 经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223567, encodeId=1624122356e85, content=偏重的研究方向：骨骼衰老 经验分享：投稿已经一周了，一直with editor in chief ，大家遇到过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKHJoeMDwT8ic73jBc5wUdyQXpogRZA8D2ibh5gOicQ2Vs2xrKjGAdxic8jNfnNICEXZuUNeapibUJooNg/0, createdBy=76982150486, createdName=术士话剧, createdTime=Tue May 31 11:14:53 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省)]

2022-09-09 ms4000000851485808

7.1 投稿
7.2-7.24 with editor in chief
7.25-8.4 under review
8.5-8.19 with supervising editor
8.20-9.5 under review
9.6-9.7 with supervising editor
9.8-至今 In review
已经两个多月了，想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见

94 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1248213, encodeId=46f912482132d, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 已经两个多月了，想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=ms4000000851485808, createdTime=Fri Sep 09 21:44:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248205, encodeId=0cdc12482058a, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=12307963m39暂无昵称, createdTime=Fri Sep 09 21:19:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147495, encodeId=4453214e49507, content=投稿命中率:25.0 经验分享：2022/10/31 投稿 2022/11/4 With supervising editor 2022/11/5 Under review 2022/11/14 In Review 2022/12/1 Decision：Major revision 2023/5/8 Revision submitted 2023/6/5 Decision： Minor revision 2023/6/14 Revision submitted 2023/6/14 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Jul 11 16:07:53 CST 2023, time=2023-07-11, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2153075, encodeId=03fd21530e538, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.3.7提交 2023.4.20审稿意见回来 major revision 2023.6.15 提交返修稿 2023.8.8 接收 想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed Aug 16 19:13:02 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向：骨健康;蛋白质组 经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2136489, encodeId=3113213648953, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed May 17 12:20:19 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0 偏重的研究方向：细胞衰老 经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223567, encodeId=1624122356e85, content=偏重的研究方向：骨骼衰老 经验分享：投稿已经一周了，一直with editor in chief ，大家遇到过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKHJoeMDwT8ic73jBc5wUdyQXpogRZA8D2ibh5gOicQ2Vs2xrKjGAdxic8jNfnNICEXZuUNeapibUJooNg/0, createdBy=76982150486, createdName=术士话剧, createdTime=Tue May 31 11:14:53 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省)]

2022-09-09 12307963m39暂无昵称

7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了

74 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1248213, encodeId=46f912482132d, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 已经两个多月了，想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=ms4000000851485808, createdTime=Fri Sep 09 21:44:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248205, encodeId=0cdc12482058a, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=12307963m39暂无昵称, createdTime=Fri Sep 09 21:19:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147495, encodeId=4453214e49507, content=投稿命中率:25.0 经验分享：2022/10/31 投稿 2022/11/4 With supervising editor 2022/11/5 Under review 2022/11/14 In Review 2022/12/1 Decision：Major revision 2023/5/8 Revision submitted 2023/6/5 Decision： Minor revision 2023/6/14 Revision submitted 2023/6/14 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Jul 11 16:07:53 CST 2023, time=2023-07-11, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2153075, encodeId=03fd21530e538, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.3.7提交 2023.4.20审稿意见回来 major revision 2023.6.15 提交返修稿 2023.8.8 接收 想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed Aug 16 19:13:02 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向：骨健康;蛋白质组 经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2136489, encodeId=3113213648953, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed May 17 12:20:19 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0 偏重的研究方向：细胞衰老 经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223567, encodeId=1624122356e85, content=偏重的研究方向：骨骼衰老 经验分享：投稿已经一周了，一直with editor in chief ，大家遇到过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKHJoeMDwT8ic73jBc5wUdyQXpogRZA8D2ibh5gOicQ2Vs2xrKjGAdxic8jNfnNICEXZuUNeapibUJooNg/0, createdBy=76982150486, createdName=术士话剧, createdTime=Tue May 31 11:14:53 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省)]

2023-07-11 lkjzlzq 来自云南省

投稿命中率:25.0
经验分享：2022/10/31 投稿
2022/11/4 With supervising editor
2022/11/5 Under review
2022/11/14 In Review
2022/12/1 Decision：Major revision

2023/5/8 Revision submitted
2023/6/5 Decision： Minor revision

2023/6/14 Revision submitted
2023/6/14 Accepted

10 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1248213, encodeId=46f912482132d, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 已经两个多月了，想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=ms4000000851485808, createdTime=Fri Sep 09 21:44:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248205, encodeId=0cdc12482058a, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=12307963m39暂无昵称, createdTime=Fri Sep 09 21:19:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147495, encodeId=4453214e49507, content=投稿命中率:25.0 经验分享：2022/10/31 投稿 2022/11/4 With supervising editor 2022/11/5 Under review 2022/11/14 In Review 2022/12/1 Decision：Major revision 2023/5/8 Revision submitted 2023/6/5 Decision： Minor revision 2023/6/14 Revision submitted 2023/6/14 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Jul 11 16:07:53 CST 2023, time=2023-07-11, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2153075, encodeId=03fd21530e538, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.3.7提交 2023.4.20审稿意见回来 major revision 2023.6.15 提交返修稿 2023.8.8 接收 想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed Aug 16 19:13:02 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向：骨健康;蛋白质组 经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2136489, encodeId=3113213648953, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed May 17 12:20:19 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0 偏重的研究方向：细胞衰老 经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223567, encodeId=1624122356e85, content=偏重的研究方向：骨骼衰老 经验分享：投稿已经一周了，一直with editor in chief ，大家遇到过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKHJoeMDwT8ic73jBc5wUdyQXpogRZA8D2ibh5gOicQ2Vs2xrKjGAdxic8jNfnNICEXZuUNeapibUJooNg/0, createdBy=76982150486, createdName=术士话剧, createdTime=Tue May 31 11:14:53 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省)]

2023-08-16 ms9000001212726085 来自广东省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：2023.3.7提交
2023.4.20审稿意见回来 major revision
2023.6.15 提交返修稿
2023.8.8 接收
想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？

7 0

[GetPortalCommentsPageByObjectIdResponse(id=1248213, encodeId=46f912482132d, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 已经两个多月了，想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=ms4000000851485808, createdTime=Fri Sep 09 21:44:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248205, encodeId=0cdc12482058a, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=12307963m39暂无昵称, createdTime=Fri Sep 09 21:19:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147495, encodeId=4453214e49507, content=投稿命中率:25.0 经验分享：2022/10/31 投稿 2022/11/4 With supervising editor 2022/11/5 Under review 2022/11/14 In Review 2022/12/1 Decision：Major revision 2023/5/8 Revision submitted 2023/6/5 Decision： Minor revision 2023/6/14 Revision submitted 2023/6/14 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Jul 11 16:07:53 CST 2023, time=2023-07-11, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2153075, encodeId=03fd21530e538, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.3.7提交 2023.4.20审稿意见回来 major revision 2023.6.15 提交返修稿 2023.8.8 接收 想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed Aug 16 19:13:02 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向：骨健康;蛋白质组 经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2136489, encodeId=3113213648953, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed May 17 12:20:19 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0 偏重的研究方向：细胞衰老 经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223567, encodeId=1624122356e85, content=偏重的研究方向：骨骼衰老 经验分享：投稿已经一周了，一直with editor in chief ，大家遇到过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKHJoeMDwT8ic73jBc5wUdyQXpogRZA8D2ibh5gOicQ2Vs2xrKjGAdxic8jNfnNICEXZuUNeapibUJooNg/0, createdBy=76982150486, createdName=术士话剧, createdTime=Tue May 31 11:14:53 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省)]

2023-05-29 湖来自广东省

偏重的研究方向：骨健康;蛋白质组
经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review

24 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1248213, encodeId=46f912482132d, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 已经两个多月了，想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=ms4000000851485808, createdTime=Fri Sep 09 21:44:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248205, encodeId=0cdc12482058a, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=12307963m39暂无昵称, createdTime=Fri Sep 09 21:19:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147495, encodeId=4453214e49507, content=投稿命中率:25.0 经验分享：2022/10/31 投稿 2022/11/4 With supervising editor 2022/11/5 Under review 2022/11/14 In Review 2022/12/1 Decision：Major revision 2023/5/8 Revision submitted 2023/6/5 Decision： Minor revision 2023/6/14 Revision submitted 2023/6/14 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Jul 11 16:07:53 CST 2023, time=2023-07-11, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2153075, encodeId=03fd21530e538, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.3.7提交 2023.4.20审稿意见回来 major revision 2023.6.15 提交返修稿 2023.8.8 接收 想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed Aug 16 19:13:02 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向：骨健康;蛋白质组 经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2136489, encodeId=3113213648953, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed May 17 12:20:19 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0 偏重的研究方向：细胞衰老 经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223567, encodeId=1624122356e85, content=偏重的研究方向：骨骼衰老 经验分享：投稿已经一周了，一直with editor in chief ，大家遇到过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKHJoeMDwT8ic73jBc5wUdyQXpogRZA8D2ibh5gOicQ2Vs2xrKjGAdxic8jNfnNICEXZuUNeapibUJooNg/0, createdBy=76982150486, createdName=术士话剧, createdTime=Tue May 31 11:14:53 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省)]

2023-05-17 ms9000001212726085 来自广东省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1248213, encodeId=46f912482132d, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 已经两个多月了，想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=ms4000000851485808, createdTime=Fri Sep 09 21:44:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248205, encodeId=0cdc12482058a, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=12307963m39暂无昵称, createdTime=Fri Sep 09 21:19:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147495, encodeId=4453214e49507, content=投稿命中率:25.0 经验分享：2022/10/31 投稿 2022/11/4 With supervising editor 2022/11/5 Under review 2022/11/14 In Review 2022/12/1 Decision：Major revision 2023/5/8 Revision submitted 2023/6/5 Decision： Minor revision 2023/6/14 Revision submitted 2023/6/14 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Jul 11 16:07:53 CST 2023, time=2023-07-11, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2153075, encodeId=03fd21530e538, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.3.7提交 2023.4.20审稿意见回来 major revision 2023.6.15 提交返修稿 2023.8.8 接收 想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed Aug 16 19:13:02 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向：骨健康;蛋白质组 经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2136489, encodeId=3113213648953, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed May 17 12:20:19 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0 偏重的研究方向：细胞衰老 经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223567, encodeId=1624122356e85, content=偏重的研究方向：骨骼衰老 经验分享：投稿已经一周了，一直with editor in chief ，大家遇到过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKHJoeMDwT8ic73jBc5wUdyQXpogRZA8D2ibh5gOicQ2Vs2xrKjGAdxic8jNfnNICEXZuUNeapibUJooNg/0, createdBy=76982150486, createdName=术士话剧, createdTime=Tue May 31 11:14:53 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省)]

2021-06-01 胡同串子羊

投稿命中率:25.0
偏重的研究方向：细胞衰老
经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。

100 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=1248213, encodeId=46f912482132d, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 已经两个多月了，想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=ms4000000851485808, createdTime=Fri Sep 09 21:44:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248205, encodeId=0cdc12482058a, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=12307963m39暂无昵称, createdTime=Fri Sep 09 21:19:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147495, encodeId=4453214e49507, content=投稿命中率:25.0 经验分享：2022/10/31 投稿 2022/11/4 With supervising editor 2022/11/5 Under review 2022/11/14 In Review 2022/12/1 Decision：Major revision 2023/5/8 Revision submitted 2023/6/5 Decision： Minor revision 2023/6/14 Revision submitted 2023/6/14 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Jul 11 16:07:53 CST 2023, time=2023-07-11, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2153075, encodeId=03fd21530e538, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.3.7提交 2023.4.20审稿意见回来 major revision 2023.6.15 提交返修稿 2023.8.8 接收 想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed Aug 16 19:13:02 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向：骨健康;蛋白质组 经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2136489, encodeId=3113213648953, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed May 17 12:20:19 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0 偏重的研究方向：细胞衰老 经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223567, encodeId=1624122356e85, content=偏重的研究方向：骨骼衰老 经验分享：投稿已经一周了，一直with editor in chief ，大家遇到过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKHJoeMDwT8ic73jBc5wUdyQXpogRZA8D2ibh5gOicQ2Vs2xrKjGAdxic8jNfnNICEXZuUNeapibUJooNg/0, createdBy=76982150486, createdName=术士话剧, createdTime=Tue May 31 11:14:53 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省)]

2022-05-31 术士话剧

偏重的研究方向：骨骼衰老
经验分享：投稿已经一周了，一直with editor in chief ，大家遇到过这种情况吗？

68 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1248213, encodeId=46f912482132d, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 已经两个多月了，想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=ms4000000851485808, createdTime=Fri Sep 09 21:44:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248205, encodeId=0cdc12482058a, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=12307963m39暂无昵称, createdTime=Fri Sep 09 21:19:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147495, encodeId=4453214e49507, content=投稿命中率:25.0 经验分享：2022/10/31 投稿 2022/11/4 With supervising editor 2022/11/5 Under review 2022/11/14 In Review 2022/12/1 Decision：Major revision 2023/5/8 Revision submitted 2023/6/5 Decision： Minor revision 2023/6/14 Revision submitted 2023/6/14 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Jul 11 16:07:53 CST 2023, time=2023-07-11, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2153075, encodeId=03fd21530e538, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.3.7提交 2023.4.20审稿意见回来 major revision 2023.6.15 提交返修稿 2023.8.8 接收 想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed Aug 16 19:13:02 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向：骨健康;蛋白质组 经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2136489, encodeId=3113213648953, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed May 17 12:20:19 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0 偏重的研究方向：细胞衰老 经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223567, encodeId=1624122356e85, content=偏重的研究方向：骨骼衰老 经验分享：投稿已经一周了，一直with editor in chief ，大家遇到过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKHJoeMDwT8ic73jBc5wUdyQXpogRZA8D2ibh5gOicQ2Vs2xrKjGAdxic8jNfnNICEXZuUNeapibUJooNg/0, createdBy=76982150486, createdName=术士话剧, createdTime=Tue May 31 11:14:53 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省)]

2022-09-19 ms7000000167420570

9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗

72 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1248213, encodeId=46f912482132d, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 已经两个多月了，想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=ms4000000851485808, createdTime=Fri Sep 09 21:44:11 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248205, encodeId=0cdc12482058a, content=7.1 投稿 7.2-7.24 with editor in chief 7.25-8.4 under review 8.5-8.19 with supervising editor 8.20-9.5 under review 9.6-9.7 with supervising editor 9.8-至今 In review 想请教投过这个期刊上岸的大神，这后边还有什么步骤大概多久才能回来一审意见，已经两个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6742377574, createdName=12307963m39暂无昵称, createdTime=Fri Sep 09 21:19:40 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147495, encodeId=4453214e49507, content=投稿命中率:25.0 经验分享：2022/10/31 投稿 2022/11/4 With supervising editor 2022/11/5 Under review 2022/11/14 In Review 2022/12/1 Decision：Major revision 2023/5/8 Revision submitted 2023/6/5 Decision： Minor revision 2023/6/14 Revision submitted 2023/6/14 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Jul 11 16:07:53 CST 2023, time=2023-07-11, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2153075, encodeId=03fd21530e538, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2023.3.7提交 2023.4.20审稿意见回来 major revision 2023.6.15 提交返修稿 2023.8.8 接收 想请教其他上岸的大佬们接收后杂志社移交给了wiley出版社，之后收到wiley的license等确认，并交了OA费，那么多久才会收到proof呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed Aug 16 19:13:02 CST 2023, time=2023-08-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2139663, encodeId=e74b2139663d4, content=偏重的研究方向：骨健康;蛋白质组 经验分享：投稿五天，现在处于With Supervising Editor状态，请问接收过的同行这个状态处于什么阶段，还有多久Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a4f2006670, createdName=湖, createdTime=Mon May 29 11:59:07 CST 2023, time=2023-05-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2136489, encodeId=3113213648953, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：Aging cell 今年影响因子预测将大幅度下降，还值得投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed08250774, createdName=ms9000001212726085, createdTime=Wed May 17 12:20:19 CST 2023, time=2023-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=970070, encodeId=9d349e007046, content=投稿命中率:25.0 偏重的研究方向：细胞衰老 经验分享：投了一篇，7张大图，纯细胞研究。一审一个半月，4个审稿人，一堆问题，还需要补实验。修改用了三个月，中间还申请了一次延迟，补了不少实验。修回去之后，二审两个礼拜，直接接收。总体很nice，是一本非常认真的期刊，审稿人水平很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYPpOWCGE1Mib6UG4HaWVsx4yy5YmEm7nkQHXia8UqeENm5SmukCcXhib2PTRKa8n85enPSeTgRdZBQ/132, createdBy=eca21956848, createdName=胡同串子羊, createdTime=Tue Jun 01 14:36:26 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223567, encodeId=1624122356e85, content=偏重的研究方向：骨骼衰老 经验分享：投稿已经一周了，一直with editor in chief ，大家遇到过这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKHJoeMDwT8ic73jBc5wUdyQXpogRZA8D2ibh5gOicQ2Vs2xrKjGAdxic8jNfnNICEXZuUNeapibUJooNg/0, createdBy=76982150486, createdName=术士话剧, createdTime=Tue May 31 11:14:53 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089114, encodeId=0c3f20891145a, content=9月15日下午投的稿，晚上状态变成Under review，然后9月18日上午发现状态已经变成Awaiting EIC desicion，请问是要被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ceae5681716, createdName=ms7000000167420570, createdTime=Mon Sep 19 22:00:46 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117172, encodeId=2d4a211e172b3, content=各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11e82202257, createdName=120b955dm62暂无昵称, createdTime=Thu Mar 02 09:28:22 CST 2023, time=2023-03-02, status=1, ipAttribution=浙江省)]

2023-03-02 120b955dm62暂无昵称来自浙江省

各位大佬，投稿AGING CELL直接就With Supervising Editor，状态七天了，是不是要被拒了

91 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

科研工具

写作工具

其他工具

平台业务解决方案

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务